A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab
Articolo
Data di Pubblicazione:
2022
Abstract:
Diabetes mellitus (DM) is common and recognized as a risk factor for developing non-small cell lung cancer (NSCLC) while the prognostic evaluation is still controversial. As immunotherapy is widely used in clinical practice, its efficacy and survival should be investigated in patients with DM.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Diabetes mellitus (DM); hemoglobin A1c (HbA1c); immunotherapy; non-small cell lung cancer (NSCLC)
Elenco autori:
Shen, Yinchen; Li, Jiaqi; Qiang, Huiping; Lei, Yuqiong; Chang, Qing; Zhong, Runbo; Stella, Giulia Maria; Gelsomino, Francesco; Kim, Yeon Wook; Abed, Afaf; Qian, Jialin; Chu, Tianqing
Link alla scheda completa:
Pubblicato in: